Clinical trials on the use of psilocybin (PSL) to treat depression are promising, but still in preliminary stages. Additionally, they are confounded by the presence of hallucinations, which may not be necessary for its clinical effectiveness but create challenges when designing experiments. Results from our lab have also indicated potential antidepressant efficacy for a number […]